Krakow, Poland – 21 May 2020 – Ryvu Therapeutics (WSE:RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology, announced today that the company will present at the Jefferies Virtual Healthcare Conference, taking place June 2 to June 4, 2020.

Pawel Przewiezlikowski, Chief Executive Officer of Ryvu Therapeutics, is scheduled to present a corporate overview on Tuesday, June 2 at 9:30am (ET). A webcast of the presentation will be available live, as well as after the conference: http://wsw.com/webcast/jeff126/rvu/

For additional information about the Jefferies Virtual Healthcare Conference: https://www.jefferies.com/IdeasAndPerspectives/Conferences/325/060220